P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

Detalles Bibliográficos
Autores principales: Yenerel, M. N., Sicre de Fontbrune, F., Piatek, C., Sahin, F., Füreder, W., Ogawa, M., Tomazos, I., Doll, H., Ozol-Godfrey, A., Sierra, J. R., Szer, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430576/
http://dx.doi.org/10.1097/01.HS9.0000846136.56070.c0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430576/
http://dx.doi.org/10.1097/01.HS9.0000846136.56070.c0

Ejemplares similares